Sunitinib–CLIO Conjugate: A VEGFR/PDGFR-Targeting Active MR Probe

Gwang Tae Noh,Mi-hyun Kim,Ji-Yeon Suh,Youngkyu Song,Chang Kyung Lee,Jin Hee Baek,Yong Seok Lee,Gyunggoo Cho,Eunju Kim,Young Ro Kim,H. Cho,Dongyeol Lim,Jeong Kon Kim

Sunitinib–CLIO Conjugate: A VEGFR/PDGFR-Targeting Active MR Probe

2014

Gwang Tae Noh
Mi-hyun Kim
Ji-Yeon Suh
Youngkyu Song
Chang Kyung Lee
Jin Hee Baek
Yong Seok Lee
Gyunggoo Cho
Eunju Kim
Young Ro Kim
H. Cho
Dongyeol Lim
Jeong Kon Kim

Purpose This study was conducted to evaluate feasibility of sunitinib–CLIO conjugate as a vascular endothelial growth factor receptor/platelet-derived growth factor receptor (VEGFR/PDGFR)-specific magnetic resonance (MR) probe.

Keywords:

Medicine
Nuclear medicine
Conjugate
Cancer research
Angiogenesis
Magnetic resonance imaging
Vascular Endothelial Growth Factor Receptor
VEGF receptors
Growth factor receptor
Sunitinib
Platelet-derived growth factor receptor

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations